NEVOFARMA

We Expand Access to Innovative Therapies for Global Health

NEVOFARMA is a pharmaceutical access and distribution company committed to bridging global innovation with patients in need. By collaborating with biotechnology innovators, international pharmaceutical manufacturers, and healthcare institutions, we support the introduction of advanced therapies—especially for rare and underserved conditions.

Our work is guided by scientific integrity, regulatory excellence, and a firm dedication to improving patient outcomes across diverse healthcare systems.

“We work tirelessly to bring products that make a real difference in people’s lives and help improve overall health and wellbeing''

Innovation and Access

SOLUTIONS & PARTNERSHIPS

Our goal is to empower healthcare providers and improve outcomes for patients affected by critical health conditions, rare and ultra-rare diseases.

Expanding access to these therapies is a real challenge in many parts of the world, due to  different barriers. Just at that point, NEVOFARMA works to bridge the gap by partnering with pharmaceutical innovators to bring advanced therapies where they are needed most.

Rare Diseases
0 +
People affected worldwide.
0 + Million

Globally, over 300 million people are affected by rare diseases.

Of cases begin in childhood.
~ 0 %

Approximately 50% of rare diseases begin in childhood.

~ 0 +

Patients consult an average of 10 doctors before receiving a diagnosis.